Literature DB >> 19527471

Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis.

Mariko Seishima1, Yoshinao Shibuya, Genichi Kato, Takahiko Aoki.   

Abstract

Double filtration plasmapheresis (DFPP) is often performed as a treatment for autoimmune diseases including pemphigus vulgaris. We report a pemphigus vulgaris patient with subcutaneous bleeding, gradually spreading over a period of 10 days after DFPP. In this patient, factor XIII activity was markedly decreased. In three other patients, factor XIII activities were markedly reduced the day following DFPP, were but restored by days 7-10. From these findings, subcutaneous bleeding may have occurred in the present patient due to a delayed recovery of the decreased factor XIII activity after DFPP. Therefore, decreased factor XIII activity could be a critical cause of subcutaneous bleeding after DFPP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527471     DOI: 10.1111/j.1744-9987.2009.00688.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  2 in total

1.  Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome.

Authors:  Arata Osanami; Masatoshi Kanda; Tatsuya Sato; Chikako Akazawa; Shuhei Baba; Hiroaki Komatsu; Kazuyuki Murase; Tomohisa Yamashita; Toshiyuki Yano
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055

Review 2.  Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan.

Authors:  Shiho Amano; Kohei Oka; Yutaka Sato; Chiaki Sano; Ryuichi Ohta
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.